AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer. [PDF]
Nouri M +8 more
europepmc +1 more source
Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib. [PDF]
Fischer J +10 more
europepmc +1 more source
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer. [PDF]
Zhang G +9 more
europepmc +1 more source
Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein. [PDF]
Tsuji K, Tamamura H, Burke TR.
europepmc +1 more source
SBE13, a newly identified inhibitor of inactive polo-like kinase 1
Keppner Sarah +3 more
doaj +1 more source
MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer. [PDF]
Williams I +10 more
europepmc +1 more source
Testis- and ovary-expressed polo-like kinase transcripts and gene duplications affect male fertility when expressed in the Drosophila melanogaster germline. [PDF]
Najera P +6 more
europepmc +1 more source
A limitation lifted: A conditional knockdown system reveals essential roles for Polo-like kinase and Aurora kinase 1 in <i>Trypanosoma cruzi</i> cell division. [PDF]
Wiedeman J, Harrison R, Etheridge RD.
europepmc +1 more source
Polo-like kinase inhibition leads to neuroprotection of neurons bearing alpha-synuclein Lewy body-like inclusions <i>in vivo</i>. [PDF]
Rose EP, Banga JS, Unni VK.
europepmc +1 more source
Upregulation of phosphatase and tensin homolog deleted on chromosome ten inhibits lung cancer cell proliferation by suppressing the oncogene polo-like kinase 1 and inducing autophagy. [PDF]
Jiang W, Wang P, Huang L.
europepmc +1 more source

